Patient representatives' contributions to the benefit‐risk assessment tasks of the European Medicines Agency scientific committees

Por Bernabe, Rosemarie D L C, van Thiel, Ghislaine J M W, van Delden, Johannes
Publicado no Br J Clin Pharmacol (2014)

What do international ethics guidelines say in terms of the scope of medical research ethics?

Por Bernabe, Rosemarie D. L. C., van Thiel, Ghislaine J. M. W., van Delden, Johannes J. M.
Publicado no BMC Med Ethics (2016)

The risk-benefit task of research ethics committees: An evaluation of current approaches and the need to incorporate decision studies methods

Por Bernabe, Rosemarie D L C, van Thiel, Ghislaine J M W, Raaijmakers, Jan A M, van Delden, Johannes J M
Publicado em 2012

Stakeholders’ views on the ethical challenges of pragmatic trials investigating pharmaceutical drugs

Por Kalkman, Shona, van Thiel, Ghislaine J. M. W., Grobbee, Diederick E., Meinecke, Anna-Katharina, Zuidgeest, Mira G. P., van Delden, Johannes J. M.
Publicado no Trials (2016)

A 10-Year Analysis of the Effects of Media Coverage of Regulatory Warnings on Antidepressant Use in The Netherlands and UK

Por Hernandez, Juan Francisco, Mantel-Teeuwisse, Aukje K., van Thiel, Ghislaine J. M. W., Belitser, Svetlana V., Warmerdam, Jan, de Valk, Vincent, Raaijmakers, Jan A. M., Pieters, Toine
Publicado em 2012